DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

JP Morgan Maintains Neutral on Esperion Therapeutics, Raises Price Target to $47

JP Morgan maintains Esperion Therapeutics (NASDAQ:ESPR) with a Neutral and raises the price target from $46 to $47.

Benzinga · 02/28/2020 14:51

JP Morgan maintains Esperion Therapeutics (NASDAQ:ESPR) with a Neutral and raises the price target from $46 to $47.